Figure 1

![Figure 1: Overview of androgenetic alopecia pathophysiology and the role of 5-alpha reductase in converting testosterone to dihydrotestosterone. The molecular mechanism underlying hair miniaturization is illustrated.]()

> Source: Silvia Tampucci et al. "Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to t." *Pharmaceutics*, 2022. PMID: [35214018](https://pubmed.ncbi.nlm.nih.gov/35214018/)

<figure>
  <img src="" alt="Overview of androgenetic alopecia pathophysiology and the role of 5-alpha reductase in converting testosterone to dihydrotestosterone. The molecular mechanism underlying hair miniaturization is illustrated." />
  <figcaption>Figure 1. Overview of androgenetic alopecia pathophysiology and the role of 5-alpha reductase in converting testosterone to dihydrotestosterone. The molecular mechanism underlying hair miniaturization is illustrated.<br>  Source: Silvia Tampucci et al. "Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to t." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35214018/">35214018</a></figcaption>
</figure>